“Research on Effectiveness of the Global Infectious Disease Policy and Law” - «Promotion of Commercial Health Checkups and Lung Cancer Overdiagnosis in China, South Korea, and Taiwan»

04.06.2024 11:45 – 13:45

Dr. Feng-Jen Tsai, Director and Professor, Master and PhD Program in Global Health and Health Security, Taipei Medical University

“Research on Effectiveness of the Global Infectious Disease Policy and Law”

The frequent occurrence of global infectious diseases, especially the outbreak and spread of COVID-19, has led to a renewed understanding of the importance of infectious disease prevention and control worldwide. The current foundation of global infectious disease prevention and control policies is the International Health Regulations (IHR 2005), particularly the provisions of developing core surveillance and response capabilities. This presentation will begin by examining the associations among countries' self-reported IHR 2005 capacity assessments and infectious disease control outcomes, as well as the relationships between outbreak reporting obligations and the socioeconomic environments of countries. Further, the presentation will analyze the changes in global policy content and its impact on the countries' self-assessed and joint external evaluation (JEE) core surveillance and response capabilities.

Professor Wayne GaoAssociate Professor, Ph.D. Program in Global Health and Health Security
«Promotion of Commercial Health Checkups and Lung Cancer Overdiagnosis in China, South Korea, and Taiwan»
 The notion that "more is merrier" does not hold true in medicine, particularly concerning detecting asymptomatic diseases in low-risk populations. This study investigates the implications of increased screening for low-risk populations. Using a population-based ecological cohort study design, we examined the effects of heightened lung cancer screening in a largely non-smoking population. Our findings reveal a significant rise in the detection of early-stage lung cancer, yet no corresponding decrease in late-stage incidence or mortality rates. Notably, while the five-year survival rates have more than doubled, lung cancer mortality has remained stable despite a dramatic increase in volume and cost of invasive surgical procedures. These results suggest a notable phenomenon of overdiagnosis/overtreatment and artificially inflated survival rates associated with lung cancer screening initiatives. Importantly, our findings are consistent with subsequent studies conducted in China and South Korea, underscoring the broader implications of our research.

Lieu

Bâtiment: Campus Biotech

Lunch - Hall H8
Colloque - H8.01.F

entrée libre

Fichiers joints

	Colloque_ISG_04JUN_W_Gao_FJ_Tsai.png	471.9 Kb
	image.png	2.3 Kb